Too much of a risk for Alzheimers Drug

Discussion in 'BiogenIdec' started by anonymous, Feb 28, 2020 at 5:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Any idea when interviews with Sales Mangers start? Have all the Managers been hired yet?
     

  2. Jan4RDK

    Jan4RDK new user

    Joined:
    May 28, 2020
    Messages:
    3
    Likes Received:
    0
    Sales Managers start! Yes but I didn't make it to their interview
     
  3. Jan4RDK

    Jan4RDK new user

    Joined:
    May 28, 2020
    Messages:
    3
    Likes Received:
    0
  4. anonymous

    anonymous Guest

    Enter at your own risk. Big pharma all over again. Landing pad for cast offs.
     
  5. anonymous

    anonymous Guest

    What's the safety profile look like?

    I was on the team that launched Cognex way back when. It showed little improvement in Alzheimers, but it did slow the progression. It, too, was hailed as THE breakthrough for Alzheimers. Unfortunately, after a short (approximately 6 werks) on the market, the FDA determined the increase in liver enzyme function problems caused them to pull it from the market.

    That was over 20 years ago. I hope this drug has some efficacy and lots of safety!
     
  6. anonymous

    anonymous Guest

    The managers that they have assembled are uninspired big pharma rejects reading a script and just hanging on while they desperately try to stay in the game.
     
  7. anonymous

    anonymous Guest

    B I G N O and Bingo was his name! Spot fucking on!
     
  8. anonymous

    anonymous Guest

    Bunch of stiff neck Useless SOBs reading an interview guide that won’t be good for anything more than approving expense reports and enforcing daily call average metrics.
     
  9. anonymous

    anonymous Guest

    Looks like that HR drone or Patient Advocate attacking anyone with a realistic & sober-thought on Adu, is on vacation
     
  10. anonymous

    anonymous Guest

    What’s the typical severance here like?
     
  11. anonymous

    anonymous Guest

    Week and a half per year of service plus four $38 Smart and Final Gift Cards
     
  12. anonymous

    anonymous Guest

    I got my DM call next week, where are nost of the manager coming from , some one said avanir which is joke
     
  13. anonymous

    anonymous Guest

    Managers coming from sage...former Novartis employees bc of President. Amgen metric people..
     
  14. Vicki Didde

    Vicki Didde new user

    Joined:
    Jun 30, 2020
    Messages:
    1
    Likes Received:
    0
    ALZ is a go! Recruiters actively recruiting open leadership roles.
     
  15. anonymous

    anonymous Guest

    Anyone know when the ALZ offers go out?
     
  16. anonymous

    anonymous Guest

    clones and drones. Perfect fit for the primary care culture. If you like following a script, not thinking on your feet and working where the word loyalty is not in the dictionary you just hit the lottery!
     
  17. anonymous

    anonymous Guest

    Preach it! Pretty much nailed it.
     
  18. anonymous

    anonymous Guest


    Is the customer base neurology and primary care? Territories seem small for specialty and base isn’t as high as expected. Just doesn’t seem worth the risk. I didn’t think of Biogen as a primary care company. This is weird.
     
  19. anonymous

    anonymous Guest

    What is the base as far as you are hearing?
     
  20. anonymous

    anonymous Guest

    Yes small territories with counter parts and primary care targets. This is not what it’s cracked up to be. Hell no guarantee that there will even be a product to sell. Even if it gets approved it will likely be months before having it in your bags to sell. Buyer Beware